Serum uric acid and the risk of cardiovascular and renal disease.
about
Metabolic syndrome, serum uric acid and renal risk in patients with T2D.Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in miceImpact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment optionsHyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population.Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease after Treatment.Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study.Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS StudyThe risk of atrial fibrillation in patients with gout: a nationwide population-based study.Hypertension burden in Luxembourg: Individual risk factors and geographic variations, 2013 to 2015 European Health Examination Survey.Serum uric acid levels and cardiovascular disease: the Gordian knot.An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.A higher baseline plasma uric acid level is an independent predictor of arterial stiffness: A community-based prospective study.Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report.Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population.Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.Uric Acid Amplifies Aβ Amyloid Effects Involved in the Cognitive Dysfunction/Dementia: Evidences From an Experimental Model In Vitro.SGLT2 Inhibitors: Benefit/Risk Balance.Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis.The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.Diet-independent relevance of serum uric acid for blood pressure in a representative population sample.Relationship between hyperuricemia and risk of coronary heart disease in a middle-aged and elderly Chinese population.Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging.Uric acid, renal function and risk of hypoglycaemia in Chinese type 2 diabetes patients.Phloretin attenuates hyperuricemia-induced endothelial dysfunction through co-inhibiting inflammation and GLUT9-mediated uric acid uptake.Association between Sex Hormone and Blood Uric Acid in Male Patients with Type 2 Diabetes.Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.Sex-related relationships between uric acid and target organ damage in hypertension.Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality.Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice.The problem of cardio-renal diseases in patients with gout.Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome.Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies.Interaction between gender and uric acid on hemoglobin A1c in community-dwelling persons.Effects of serum uric acid on blood-pressure lowering treatment.The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies.The challenge of Mendelian randomization approach.The management of hyperuricemia: back to the pathophysiology of uric acid.
P2860
Q33579624-6F318319-C1B7-4A51-99A4-155E4B372F4FQ33646780-D4DBBB05-5C10-4426-9A0C-E1AC978BA593Q33683082-9F30162F-1059-4E3F-A5E4-B0C8AAE8D42FQ33864537-56465599-C9E9-4B95-9521-6CA10F80E79FQ33905585-2C8C691B-6231-4240-BE29-3D13F7F77E73Q33918765-8B0E8907-7011-4765-B177-173A4BDE48F2Q35877440-D7AAFA30-E93D-4C76-8B0C-8A7433C70D93Q36233048-B4769403-CB1D-43BF-A52D-06FA63B18071Q37116849-66BD1986-670A-40E8-BCF1-6A70202484EAQ37236227-D2221D8A-B09D-48AA-B86B-966F98A0D8D2Q37256963-5A1CFC71-54CF-4192-84C5-9A4EEAD757F8Q37528200-5637AA39-19BB-454D-ADED-00F9561B71BCQ37641297-DB9B3E2B-21DB-4864-8149-EE64993F8947Q37646584-CD44DCB6-48C9-4A47-9BA2-3F47B2E8E9EDQ37653449-FD2390C5-30E0-48A6-9ADD-FCAFFF20F9FCQ37674063-CD1EDAEB-8675-4A67-B561-1C88980AD729Q38648316-6A12F1EB-A1D5-41CD-8204-A42A5255793AQ38754696-F668E8F0-378D-40C7-99E2-F2044F3FFED9Q38931842-A98CA422-3887-4A5E-9370-1504831A6CF7Q38968869-3CAD4CB6-31BF-476D-8F57-5C8B43CA30D5Q39449598-F24DC739-BD84-45C8-9DA1-744F11E26E43Q39613176-A78445E1-E7CC-4099-A39C-E273C358DBEFQ40140234-108C6D79-7D67-48A7-9A6B-0CB0EFFC7CB7Q40325504-AC478F6B-042C-46D0-9D50-3F2D3F217253Q40428192-93A4C446-9632-4E7B-8713-E9338D32007DQ40493359-1FB201B1-AA40-464B-B2E1-C933E746E7A0Q42365766-6508AD74-12CD-4DDC-9CCB-882609F63941Q47120989-719A99EF-95C3-4B40-8B20-064659100BCAQ47370909-E8BBE1F7-28FE-474A-846D-524D4F0FD77DQ47419678-CC09B548-EFFD-4845-BE47-8B2A1A12E9FAQ47560571-8F001930-99BB-4819-9671-4B4E8706ACB1Q47754216-027F999B-862E-40FE-B298-82E3631F6C79Q47914665-F5E3D732-27ED-4212-9E7E-F93B43D72620Q48043806-83AE9A35-60A7-4444-ABF0-5D137EF35367Q48149746-C677BCA7-9278-461B-88F2-69C015353C64Q48289879-E56325C2-5850-4A62-9295-DAE1077E64C5Q49793125-84831C6C-25EC-40CE-B078-E9EC221A1788Q49793137-ACE594F3-6F46-43A3-84A0-ECFB20902554Q49793158-AA0F8410-5226-4402-9CC0-E579130F86F7Q49793170-1B34F5E7-D2E9-4F94-86C6-64D3890B50BE
P2860
Serum uric acid and the risk of cardiovascular and renal disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum uric acid and the risk of cardiovascular and renal disease.
@en
type
label
Serum uric acid and the risk of cardiovascular and renal disease.
@en
prefLabel
Serum uric acid and the risk of cardiovascular and renal disease.
@en
P2093
P50
P1476
Serum uric acid and the risk of cardiovascular and renal disease.
@en
P2093
Athanasios J Manolis
Claudio Borghi
Enrico Agabiti Rosei
Jan T Kielstein
Jesse Dawson
P304
1729-41; discussion 1741
P356
10.1097/HJH.0000000000000701
P577
2015-09-01T00:00:00Z